Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
AGENUS INC
10% owner at MiNK Therapeutics. Filing since 19 Oct 2021.
CIK 0001098972
Company
Date
Role
Action
Shares
Amount
Of holding
INKT
MiNK Therapeutics, Inc.
16 Oct 2023
10% owner
Bought
429
$471.56
0.0%
INKT
MiNK Therapeutics, Inc.
13 Oct 2023
10% owner
Bought
19,373
$21.31K
0.1%
INKT
MiNK Therapeutics, Inc.
12 Oct 2023
10% owner
Bought
3,173
$3.49K
0.0%
INKT
MiNK Therapeutics, Inc.
4 Oct 2023
10% owner
Bought
15,001
$16.38K
0.1%
INKT
MiNK Therapeutics, Inc.
29 Aug 2023
10% owner
Bought
29,678
$45.02K
0.1%
INKT
MiNK Therapeutics, Inc.
28 Aug 2023
10% owner
Bought
12,808
$18.57K
0.1%
INKT
MiNK Therapeutics, Inc.
24 Aug 2023
10% owner
Bought
170,244
$262.91K
0.8%
INKT
MiNK Therapeutics, Inc.
11 May 2023
10% owner
Bought
23,361
$33.35K
0.1%
INKT
MiNK Therapeutics, Inc.
10 May 2023
10% owner
Bought
22,065
$33.30K
0.1%
INKT
MiNK Therapeutics, Inc.
5 May 2023
10% owner
Bought
100,200
$95.10K
0.5%
INKT
MiNK Therapeutics, Inc.
4 May 2023
10% owner
Bought
21,473
$26.25K
0.1%
INKT
MiNK Therapeutics, Inc.
3 May 2023
10% owner
Bought
128,689
$138.84K
0.6%
INKT
MiNK Therapeutics, Inc.
19 Oct 2021
10% owner
Bought
1,400,000
$16.80M
7.2%
13 decisions on file.
